NewAmsterdam Pharma NAMS
NASDAQ NAMS
$19.98 +0.80 (+4.19%)
As of: Nov 11, 2026 · 9:58 AM EST

NewAmsterdam Pharma (NAMS) Liabilities and Shareholders Equity (2021 - 2026)

Updated

Analysis

NewAmsterdam Pharma (NAMS) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 197.43 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 147.68 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 51.41 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 205.00 Bn
10 NewAmsterdam Pharma 2.30 Bn -236.30 Mn - 687.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 687.99 Mn
Jun 30, 2026 704.45 Mn
Mar 31, 2026 732.64 Mn
Dec 31, 2025 769.28 Mn
Sep 30, 2025 786.43 Mn
Jun 30, 2025 815.11 Mn
Mar 31, 2025 818.41 Mn
Dec 31, 2024 864.62 Mn
Sep 30, 2024 439.19 Mn
Jun 30, 2024 446.69 Mn
Mar 31, 2024 488.46 Mn
Dec 31, 2023 347.10 Mn
Jun 30, 2023 511.99 Mn
Dec 31, 2022 566.71 Mn
Jun 30, 2022 608.98 Mn
Dec 31, 2021 67.70 Mn
API Access

NewAmsterdam Pharma Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NAMS&period=max&api_key=YOUR_API_KEY